Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation.
作者信息
Shah Rupal J, Emtiazjoo Amir M, Diamond Joshua M, Smith Patricia A, Roe David W, Wille Keith M, Orens Jonathan B, Ware Lorraine B, Weinacker Ann, Lama Vibha N, Bhorade Sangeeta M, Palmer Scott M, Crespo Maria, Lederer David J, Cantu Edward, Eckert George J, Christie Jason D, Wilkes David S
机构信息
1 University of Pennsylvania Philadelphia, Pennsylvania.
出版信息
Am J Respir Crit Care Med. 2014 Jun 15;189(12):1564-7. doi: 10.1164/rccm.201312-2121LE.
Abstract
摘要
相似文献
1
Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation.血浆补体水平与肺移植后的原发性移植物功能障碍及死亡率相关。
Am J Respir Crit Care Med. 2014 Jun 15;189(12):1564-7. doi: 10.1164/rccm.201312-2121LE.
2
Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.肺移植后肥胖与原发性移植物功能障碍：肺移植结局组肥胖研究。
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1055-61. doi: 10.1164/rccm.201104-0728OC.
3
Construct validity of the definition of primary graft dysfunction after lung transplantation.肺移植后原发性移植物功能障碍定义的构效关系。
J Heart Lung Transplant. 2010 Nov;29(11):1231-9. doi: 10.1016/j.healun.2010.05.013. Epub 2010 Jul 22.
4
Effect of donor preservation solution and survival in lung transplantation.供体保存液对肺移植中供体存活的影响。
J Heart Lung Transplant. 2011 Apr;30(4):414-9. doi: 10.1016/j.healun.2010.10.002. Epub 2010 Dec 4.
5
Association Between Prolonged Graft Ischemia and Primary Graft Failure or Survival Following Lung Transplantation.肺移植后供体肺长时间缺血与原发性移植物失功或存活的关系。
JAMA Surg. 2015 Jun;150(6):547-53. doi: 10.1001/jamasurg.2015.12.
6
Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation.循环细胞死亡生物标志物可预测人类肺移植的存活率。
Am J Respir Crit Care Med. 2016 Jul 1;194(1):97-105. doi: 10.1164/rccm.201510-2115OC.
7
The association of post-lung transplant acute kidney injury with mortality is independent of primary graft dysfunction: A cohort study.肺移植后急性肾损伤与死亡率的相关性与原发性移植物功能障碍无关：一项队列研究。
Clin Transplant. 2019 Oct;33(10):e13678. doi: 10.1111/ctr.13678. Epub 2019 Aug 28.
8
Risk Factors for Mortality in 272 Patients With Lung Transplant: A Multicenter Analysis of 7 Intensive Care Units.272 例肺移植患者死亡的危险因素：7 个重症监护单元的多中心分析。
Arch Bronconeumol. 2017 Aug;53(8):421-426. doi: 10.1016/j.arbres.2016.12.019. Epub 2017 Feb 27.
9
Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation.供体来源的无细胞 DNA 与活体供体肺叶移植后原发性移植物功能障碍中的急性排斥反应和氧合降低有关。
Sci Rep. 2018 Oct 18;8(1):15366. doi: 10.1038/s41598-018-33848-3.
10
Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.单中心肺移植术后原发性移植肺功能障碍的危险因素及生存影响
Transplant Proc. 2012 Oct;44(8):2462-8. doi: 10.1016/j.transproceed.2012.07.134.
引用本文的文献
1
Primary Graft Dysfunction in Lung Transplantation: An Overview of the Molecular Mechanisms.肺移植中的原发性移植功能障碍：分子机制概述
Int J Mol Sci. 2025 Jul 15;26(14):6776. doi: 10.3390/ijms26146776.
2
Temporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts.肺移植后再灌注期间补体沉积与严重原发性移植物功能障碍的时间相关性。
Am J Transplant. 2024 Apr;24(4):577-590. doi: 10.1016/j.ajt.2023.11.006. Epub 2023 Nov 15.
3
Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation.肝移植患者术前及术后血清中补体系统激活的生物标志物（C3a、C5a、sC5b-9）
Biomedicines. 2023 Jul 23;11(7):2070. doi: 10.3390/biomedicines11072070.
4
Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for delivery.补体靶向治疗移植物缺血再灌注损伤及递送的可能性。
Front Immunol. 2022 Oct 19;13:1000172. doi: 10.3389/fimmu.2022.1000172. eCollection 2022.
5
Primary graft dysfunction: what we know.原发性移植功能障碍：我们所了解的情况。
J Thorac Dis. 2021 Nov;13(11):6618-6627. doi: 10.21037/jtd-2021-18.
6
Long-term lung inflammation is reduced by estradiol treatment in brain dead female rats.脑死亡雌性大鼠用雌二醇治疗可减少长期肺部炎症。
Clinics (Sao Paulo). 2021 Aug 16;76:e3042. doi: 10.6061/clinics/2021/e3042. eCollection 2021.
7
Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review.移植肺中的缺血再灌注损伤：文献综述
Transplant Direct. 2021 Jan 7;7(2):e652. doi: 10.1097/TXD.0000000000001104. eCollection 2021 Feb.
8
A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury.一种新型损伤部位-天然抗体靶向补体抑制剂可预防肺移植损伤。
Am J Transplant. 2021 Jun;21(6):2067-2078. doi: 10.1111/ajt.16404. Epub 2021 Feb 26.
9
Sterile inflammation in thoracic transplantation.胸移植中的无菌性炎症。
Cell Mol Life Sci. 2021 Jan;78(2):581-601. doi: 10.1007/s00018-020-03615-7. Epub 2020 Aug 17.
10
Local complement activation is associated with primary graft dysfunction after lung transplantation.局部补体激活与肺移植后原发性移植物功能障碍有关。
JCI Insight. 2020 Sep 3;5(17):138358. doi: 10.1172/jci.insight.138358.
本文引用的文献
1
Role of complement activation in obliterative bronchiolitis post-lung transplantation.补体激活在肺移植后闭塞性细支气管炎中的作用。
J Immunol. 2013 Oct 15;191(8):4431-9. doi: 10.4049/jimmunol.1202242. Epub 2013 Sep 16.
2
Clinical risk factors for primary graft dysfunction after lung transplantation.肺移植后原发性移植物功能障碍的临床危险因素。
Am J Respir Crit Care Med. 2013 Mar 1;187(5):527-34. doi: 10.1164/rccm.201210-1865OC. Epub 2013 Jan 10.
3
Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.缺乏 C3aR 和 C5aR 向 CD4⁺ 细胞发出信号会导致自诱导 TGF-β1 信号和 Foxp3⁺ 调节性 T 细胞的诱导。
Nat Immunol. 2013 Feb;14(2):162-71. doi: 10.1038/ni.2499. Epub 2012 Dec 23.
4
Construct validity of the definition of primary graft dysfunction after lung transplantation.肺移植后原发性移植物功能障碍定义的构效关系。
J Heart Lung Transplant. 2010 Nov;29(11):1231-9. doi: 10.1016/j.healun.2010.05.013. Epub 2010 Jul 22.
5
Complement in organ transplantation.补体在器官移植中的作用。
Curr Opin Organ Transplant. 2010 Aug;15(4):486-91. doi: 10.1097/MOT.0b013e32833b9cb7.
6
The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.过敏毒素C3a和C5a在调节先天性和适应性免疫反应中的作用。
Inflamm Allergy Drug Targets. 2009 Jul;8(3):236-46. doi: 10.2174/187152809788681038.
7
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.国际心肺移植学会原发性肺移植功能障碍工作组报告第二部分：定义。国际心肺移植学会共识声明
J Heart Lung Transplant. 2005 Oct;24(10):1454-9. doi: 10.1016/j.healun.2004.11.049. Epub 2005 Jun 4.
8
A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.一项关于人类肺移植后缺血再灌注损伤中补体抑制的随机、安慰剂对照试验。
J Thorac Cardiovasc Surg. 2005 Feb;129(2):423-8. doi: 10.1016/j.jtcvs.2004.06.048.
9
Local synthesis of complement component C3 regulates acute renal transplant rejection.补体成分C3的局部合成调节急性肾移植排斥反应。
Nat Med. 2002 Jun;8(6):582-7. doi: 10.1038/nm0602-582.
10
Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation.在低温肺保存与移植的同基因大鼠模型中，补体激活作为原发性移植肺失功的一个原因。
Transplantation. 1997 Nov 15;64(9):1248-55. doi: 10.1097/00007890-199711150-00004.
Zotero 插件